THIS week, ther Government's Health Secretary Matt Hancock visited Oxford as part of a summit between global health ministers.

The G7 group of countries agreed to the terms of a shared vaccine passport travel scheme while in Oxford, and also discussed working together to share vaccines across the globe.

Further discussions on vaccine sharing with low-income nations is expected at the full G7 summit in Cornwall next weekend.

For now though, here is the full Q and A of our five minutes with the health secretary, showing every question we asked him, and every answer he gave.

Q. What are your priorities while you are here?

Matt Hancock: Well, I decided to hold the G7 health minsters meeting here in Oxford because Oxford has played such a central part in the world’s response to this pandemic. Of course, the Oxford-AstraZeneca vaccine which has now been delivered to half a billion people around the world – and it is more than that, because Oxford has been central to the clinical trials that have discovered that dexamethasone helps to protect people who are in hospital with Covid which is estimated to have saved over a million lives already.

So Oxford has been at the centre of the world’s response to Covid and at the forefront of the scientific response. So I thought it was an appropriate place to come to discuss what we need to do for the world to get out of this pandemic and be better prepared for future pandemics.

Q. Thanks... but can you tell me what are your priorities while you are here?

MH: The first thing is we need to make sure we build now the early warning systems that will help protect the world from anything like this from ever happening again. Future diseases that spread from animals to humans are inevitable. The question is how we can be better prepared as a world so it doesn’t have the impact this one has had.

That is the future, in the here and now we have got to make sure we get vaccines to as many people globally. Vaccination in the UK is going gangbusters, three-quarters of the adult population has now had a first jab, which I am very proud of and you can see the impact on the pandemic here but this isn’t over until it is over everywhere.

Q. On that note, one of our MPs Layla Moran, has sent a letter to you and the other G7 health ministers calling on you to sign up to an international vaccine intellectual property waiver – what are your thoughts on that?

MH: On the vaccine intellectual property waiver, that is what we have already done here in the UK. More than a year ago, we took that approach with the Oxford-AstraZeneca vaccine. We put the investment in to get that vaccine developed, a combination of Oxford University, the UK Government and AstraZeneca and we deploy it now at cost around the whole world. We have already effectively waived any charge for intellectual property for the Oxford vaccine.

Other vaccine companies are now starting to move to this approach. Pfizer last month announced that it would charge no cost for intellectual property in low-income countries, but the objective is to make sure the vaccine is available to everyone around the world and the UK is leading that approach.

Q. You spoke to other media outlets about excess UK vaccine doses – what is happening with those?

MH: As and when we have excess doses here in the UK we are open to making them available especially to low income countries, but we don’t have any excess doses. At the moment as soon as we have any doses, we get them to the NHS and the NHS gets them into people’s arms and obviously that is the big focus because we have got to make sure people are protected here.

Q. One of the issues that has come up a lot in the last couple of weeks has been care homes. One of my colleagues has spoken to the chair of the Oxfordshire Association of Care Homes who said they did not feel like there was a ‘protective ring’ around care homes in the first wave of the pandemic. Do you admit that was the case? And what has been learned?

MH: We learned a lot about the nature of the disease and how best to protect people. The plan we put in place over the summer which learned the lessons of the first wave in care homes meant that in the second wave far more people were better protected. It is one example of having learned more as the pandemic went on, as we learnt more about the science of the virus, and we learnt more about the science of the virus and we learned more about how best to protect people because this was an unprecedented situation.

And this is why learning lessons both here at home and internationally is so important.

***

What other questions would you have asked the health secretary if you had five minutes? Answer in the comments below, but please, keep it clean...